| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 2.139 | 2.245 | - | - | - | 0 | 0 | - | 0 | 0 |
| Total Income - EUR | 2.139 | 2.245 | - | - | - | 0 | 0 | - | 0 | 0 |
| Total Expenses - EUR | 2.070 | 2.050 | - | - | - | 0 | 0 | - | 0 | 0 |
| Gross Profit/Loss - EUR | 69 | 195 | - | - | - | 0 | 0 | - | 0 | 0 |
| Net Profit/Loss - EUR | 5 | 128 | - | - | - | 0 | 0 | - | 0 | 0 |
| Employees | 0 | 0 | - | - | - | 0 | 0 | - | 0 | 0 |
Check the financial reports for the company - Crispromed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.159 | 1.069 | - | - | - | 0 | 0 | - | 0 | 0 |
| Current Assets | 3.493 | 2.860 | - | - | - | 3.716 | 3.634 | - | 3.634 | 3.614 |
| Inventories | 0 | 0 | - | - | - | 0 | 0 | - | 0 | 0 |
| Receivables | 0 | 10 | - | - | - | 13 | 13 | - | 13 | 13 |
| Cash | 3.493 | 2.850 | - | - | - | 3.703 | 3.621 | - | 3.622 | 3.601 |
| Shareholders Funds | 3.840 | 3.928 | - | - | - | 3.716 | 3.634 | - | 3.634 | 3.614 |
| Social Capital | 45 | 45 | - | - | - | 41 | 40 | - | 40 | 40 |
| Debts | 1.812 | 0 | - | - | - | 0 | 0 | - | 0 | 0 |
| Income in Advance | 0 | 0 | - | - | - | 0 | 0 | - | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Crispromed S.r.l.